CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Versed +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02419547
NCT02419547N/ACompleted
CompareCT.gov

Inducibility and Stability of Ventricular Tachycardia in Patients With Structural Heart Disease Undergoing VT Ablation Under General Anesthesia (Pilot Study)

Brigham and Women's Hospital·interventional·Posted Apr 17, 2015·Updated Oct 9, 2019

In Brief

A clinical study evaluating Versed, Fentanyl, and 2 other interventions for Ventricular Tachycardia. Completed, enrolled 11 participants across 1 site.

Detailed Summary

This research study is being done to see whether general anesthesia (GA) affects our ability to start ventricular tachycardia (VT) during an VT ablation procedure. Data collected during this research study will help electrophysiologists and anesthesiologists to make the best decisions about the best anesthetic conditions to use to perform VT ablations. This research study is a "pilot" study. Pilot studies are done on a small group of subjects to learn if a larger study would be useful.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentricular Tachycardia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 17, 2015
Enrollment StartJul 1, 2014
Primary CompletionApr 26, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.2 years ago

Interventions

Verseddrug

Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia

Fentanyldrug

Phase 1: Standard induction of controled sedation with intravenous agent then programed stimulation to induce ventricular tachycardia

Propofoldrug

Phase 2: Standard induction of GETA with intravenous agent then programed stimulation to induce ventricular tachycardia

Sevofluranedrug

Phase 3: Standard induction of GETA with inhalent agent then programed stimulation to induce ventricular tachycardia